|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Brain accumula- tion of sunitinib is restricted by P - glycoprotein ( ABCB1 ) and breast cancer resistance protein (ABCG2) and can be enhanced by oral elaeridar and sunitinib coadministration 显示文摘 | TANG S C LAGAS J S LANKHEET N A | 2012 | lnt J Cancer2012，130，1： | 1 |
| 2 | A randomized phaseⅡstudy comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed nonsmall-cell lung cancer patients:the NVALT-10study显示文摘 | Aerts JG Codrington H Lankheet NA Burgers S Biesma B Dingemans AM | 2013 | Ann Oncol2013，24，11： | 1 |
| 3 | Method development and validation for the quantification of dasatinib, erlotinib, gefitinib, imatinib, lapatinib, nilotinib, sorafenib and sunitinib in human plasma by liquid chromatography coupled with tandem mass spectrometry显示文摘 | N. A. G. Lankheet M. J. X. Hillebrand H. Rosing J. H. M. Schellens J. H. Beijnen A. D. R. Huitema | 2012 | Chromatogr2012，，4： | 1 |
| 4 | Pharmacokinetically guided sunitinib dosing:a feasibility study in patients with advanced solid tumours 显示文摘 | LANKHEET N A KLOTH J S GADELLAA - VAN HOOIJDONK C G | 2014 | Br J Cancer2014，110，10： | 1 |
| 5 | A randomized phase Ⅱ study comparing erlotinib versus erlotinib with alternating chemo- therapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study显示文摘 | AertsJG Codrington H Lankheet NA | 2013 | Ann Oncol2013，24，11： | 1 |
| 6 | Brain accumulation of sunitinib is restricted by P-glycoprotein ( ABCB1 ) and breast cancer resistance protein(ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration 显示文摘 | Tang SC Lagas JS Lankheet NA | 2012 | Int J Cancer2012，130，1： | 1 |
| 7 | Brain accumulation of sunitinib is restricted by P-glycoprotein(ABCB1)and breast cancer resistance protein(ABCG2)and can be enhanced by oral elacridar and sunitinib coadministration显示文摘 | Tang SC Lagas JS Lankheet NAG | | 0，，01： | 1 |
| 8 | Brain accumulation of sunitinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration 显示文摘 | Tang SC Lagas JS Lankheet NA | 2012 | Int J Cancer2012，130，1： | 1 |
| 9 | Brain accumulation of sunitinib is restricted by P- glycoprotein (ABCB1) and breast cancer resistance protein(ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration显示文摘 | TANG SC LAGAS JS LANKHEET NA | 2012 | Int J CarLcer2012，130，1： | 1 |
| 10 | Brain accumula- tion of sunitinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration 显示文摘 | Tang SC Lagas JS Lankheet NA | 2012 | Int J Cancer2012，130，1： | 1 |
| 11 | Method development and validation for the quantification of dasatinib,erlotinib,gefitinib,imatinib,lapatinib,nilotinib,sorafenib and sunitinib in human plasma by liquid chromatography coupled with tandem mass spectrometry显示文摘 | LANKHEET NA HILLEBRAND MJ ROSING H | 2013 | Biomed Chromatogr2013，27，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员